Interní Med. 2008; 10(10): 444-448

New tobacco dependence treatment possibilities

MUDr. Eva Králíková CSc
Ústav hygieny a epidemiologie a Centrum léčby závislosti na tabáku III. interní kliniky, 1. LF UK a VFN, Praha

Smoking causes almost one fifth of all deaths in our country. We have more than 2 million of patients dependent on tobacco. Existing effective treatment should be available to each smoker. Except of specialized centers, it is mainly the short intervention delivered by first-line physicians: ask about the smoking habit, clearly recommend to stop to each smoker, assess the motivation or willingness to stop, advise how to stop to those willing to stop, recommend medication, plan controls. Although the effectivity of such intervention itself is low, its broad application (each physician during each clinical contact with the patient) would play important role in lowering the morbidity and mortality. Finally, it is the most cost-effective kind of tretment of this dependence. First-line physicians should not underestimate their possibility to influence their patients and this intervention should become standard in their daily practice.

Keywords: Key words: tobacco dependence, short intervention, nicotine replacement therapy, bupropion, varenicline.

Published: January 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíková E. New tobacco dependence treatment possibilities. Interní Med. 2008;10(10):444-448.
Download citation

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) Washington, American Psychiatric Association, 1995.
  2. Benowitz NL. Summary: Risks and Benefits, in: Benowitz NL (Ed): Nicotine Safety and Toxicity, pp.185-195, New York, Oxford University Press, 1998.
  3. Čupka J, et al. Doporučení léčby závislosti na tabáku pro praktické lékaře, Sdružení praktických lékařů ČLS JEP, 2005.
  4. Cífková R, Býma S, Češka R, Horký K, Karen I, Kunešová M, Králíková E, Rosolová H, Roztočil K, Soška V, Škrha J. Prevence kardiovaskulárních onemocnění v dospělém věku. Společné doporučení českých odborných společností, Cor Vasa 2005; 47(9 Suppl.): 3-14, Vnitřní lékařství 2005; 51(9): 1021-1036.
  5. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation. Clinical Practice Guideline No. 18. Rockville, MD, US Department of Health and Human Services, April 1996.
  6. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guideline, Rockville, MD, US Department of Health and Human Services, 2000.
  7. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service. May 2008.
  8. Framework Convention on Tobacco Control, WHO www.fctc.org.
  9. Jha P. Curbing the Epidemic, World Bank, Washington, 1999, 122 s.
  10. Králíková E, Býma S, Cífková R, Češka R, Dvořák V, Hamanová J, Horký K, Hradec J, Keller O, Konštacký S, Kos S, Kostřica R, Kunešová M, Kvapil M, Langrová K, Mayer O, Petrů V, Popov P, Raboch J, Rosolová H, Roztočil K, Sucharda P, Vorlíček J, Widimský J. Doporučení pro léčbu závislosti na tabáku, Časopis lékařů českých, 2005, 144(5): 327-333. Go to PubMed...
  11. Nicotine Replacement Therapy, Guidance for health professionals on changes in the licensing arrangements for nicotine replacement therapy, ASH, London, December 2005, www.ash.org.uk/html/cessation/smoking%20REDUCTION/nrt051229.pdf.
  12. Peto R, Lopez AD, Boreham J, Thun M. Mortality from Smoking in Developed Countries 1950-2000, 2nd edition, Oxford University Press, http://www.ctsu.ox.ac.uk/~tobacco/.
  13. Raw M. First WHO European Recommendations on the Treatment of Tobacco Dependence, Evidence based core recommendations for health care systems in Europe, World Health Organization European Partnership Project to Reduce Tobacco Dependence, June 2001. Go to original source...
  14. Sovinová H, Sadílek P, Csémy L. Vývoj prevalence kuřáctví v dospělé populaci ČR, názory a postoje občanů ČR k problematice kouření, SZÚ, 2008, výzkumná zpráva, www.szu.cz.
  15. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th revision. Geneva, WHO, 1992.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.